Search hospitals > Florida > West Palm Beach
Saint Mary's Hospital
Claim this profileWest Palm Beach, Florida 33407
Global Leader in Leukemia
Global Leader in Tumors
Conducts research for Lymphoma
Conducts research for Lymphoblastic Leukemia-Lymphoma
Conducts research for Acute Lymphoblastic Leukemia
163 reported clinical trials
3 medical researchers
Summary
Saint Mary's Hospital is a medical facility located in West Palm Beach, Florida. This center is recognized for care of Leukemia, Tumors, Lymphoma, Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia and other specialties. Saint Mary's Hospital is involved with conducting 163 clinical trials across 335 conditions. There are 3 research doctors associated with this hospital, such as Narayana Gowda, Muaz A. Alrazzak, and Robert Borrego, MD.Area of expertise
1Leukemia
Global LeaderStage II
t(8;21)(q22;q22) positive
t(16;16)(p13;q22) positive
2Tumors
Global LeaderStage I
Stage IV
Stage II
Top PIs
Narayana GowdaSaint Mary's Hospital6 years of reported clinical research
Expert in Tumors
Expert in Cancer
38 reported clinical trials
89 drugs studied
Muaz A. AlrazzakSaint Mary's Hospital6 years of reported clinical research
Studies Tumors
Studies Cancer
26 reported clinical trials
72 drugs studied
Robert Borrego, MDSt. Mary's Medical Center6 years of reported clinical research
Studies Traumatic Brain Injury
Studies Wounds and Injuries
1 reported clinical trial
2 drugs studied
Clinical Trials running at Saint Mary's Hospital
Rhabdomyosarcoma
Acute Lymphoblastic Leukemia
Osteosarcoma
Non-Hodgkin's Lymphoma
Leukemia
Germ Cell Tumors
Lymphoblastic Leukemia-Lymphoma
Lymphoma
Ovarian Tumors
Brain Tumor
Combination Chemotherapy
for Rhabdomyosarcoma
This study is evaluating whether a combination of chemotherapy drugs is more effective than a single chemotherapy drug for treating rhabdomyosarcoma.
Recruiting2 awards Phase 35 criteria
Chemotherapy
for Rhabdomyosarcoma
Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using treatment with 24 weeks of vincristine and dactinomycin (VA) and examines the use of centralized molecular risk stratification in the treatment of rhabdomyosarcoma. Another aim of the study it to find out how well patients with low risk rhabdomyosarcoma (LR-RMS) respond to standard chemotherapy when patients with VLR-RMS and patients who have rhabdomyosarcoma with DNA mutations get separate treatment. Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.
Recruiting2 awards Phase 3
Genetic Testing-Directed Therapy
for Pediatric Cancer
This study is evaluating whether genetic testing may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Mary's Hospital?
Saint Mary's Hospital is a medical facility located in West Palm Beach, Florida. This center is recognized for care of Leukemia, Tumors, Lymphoma, Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia and other specialties. Saint Mary's Hospital is involved with conducting 163 clinical trials across 335 conditions. There are 3 research doctors associated with this hospital, such as Narayana Gowda, Muaz A. Alrazzak, and Robert Borrego, MD.